Top Markets
#1 ADO Protocol ADO Protocol +195.51%
#2 Islamic Coin Islamic Coin +155.46%
#3 GoPlus Security GoPlus Security +59.58%
#4 Verus Coin Verus Coin +33.00%
#5 Starpower Starpower +27.12%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +15.11%
#8 Status Status +14.31%
#9 The Black Bull The Black Bull +12.35%
#10 o1.exchange o1.exchange +11.85%
Coin of the day
ADO Protocol ADO Protocol
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc.

Caladrius Biosciences, Inc.

CLBS
Hisse Senetlerindeki Sıralama #33298
Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical... Caladrius Biosciences, Inc. operates as a clinical-stage biopharmaceutical company primarily engaged in the development and commercialization of cellular therapies. These therapies aim to either reverse various diseases or stimulate the regeneration of compromised tissue. The company's pipeline includes several key investigational therapies: HONEDRA, which has received the prestigious SAKIGAKE designation, is undergoing Phase II clinical trials as a potential treatment for critical limb ischemia; XOWNA is currently in Phase IIb trials targeting coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy, is being evaluated for chronic kidney disease in patients prior to requiring dialysis. Previously known as NeoStem, Inc., the firm adopted its current name, Caladrius Biosciences, Inc., in June 2015. Established in 1980, the company maintains its corporate headquarters in Basking Ridge, New Jersey.
Hisse Fiyatı
$0.4264
Son senkronizasyon: 2022-09-14
Piyasa Değeri
$7.93M
Değişim (1 gün)
-16.44%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Caladrius Biosciences, Inc. (CLBS)

Kategori

Healthcare
Caladrius Biosciences, Inc. (CLBS) için kazanç
2026 itibarıyla kazanç TTM: 0
Caladrius Biosciences, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Caladrius Biosciences, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE